| Author . | Year . | Assay . | Setting . | N . | Sensitivity (%) . | Specificity . | PFS hazard ratio . | Lead time . | Reference . |
|---|---|---|---|---|---|---|---|---|---|
| Chauhan | 2023 | Bespoke PCR (uCAPP-SeQ + ULP-WGS) | MIBC | 74 | 87 | NR | 3.00 | NR | Chauhan22 |
| Zhang | 2023 | Bespoke PCR (PredicineBEACON) | MIBC | 20 | 100 | 99% | NR | NR | Zhang23 |
| Christensen | 2023 | Bespoke 50-gene PCR | MIBC | 92 | 72 | 65% | NR | NR | Christensen24 |
| Author . | Year . | Assay . | Setting . | N . | Sensitivity (%) . | Specificity . | PFS hazard ratio . | Lead time . | Reference . |
|---|---|---|---|---|---|---|---|---|---|
| Chauhan | 2023 | Bespoke PCR (uCAPP-SeQ + ULP-WGS) | MIBC | 74 | 87 | NR | 3.00 | NR | Chauhan22 |
| Zhang | 2023 | Bespoke PCR (PredicineBEACON) | MIBC | 20 | 100 | 99% | NR | NR | Zhang23 |
| Christensen | 2023 | Bespoke 50-gene PCR | MIBC | 92 | 72 | 65% | NR | NR | Christensen24 |
Abbreviations: CAPP-Seq, CAncer personalized profiling by deep sequencing; MIBC, muscle-invasive bladder cancer; MRD, molecular residual disease; NAC, neoadjuvant chemotherapy; NR, not reported; WES, whole exome sequencing; WGS, whole-genome sequencing.
| Author . | Year . | Assay . | Setting . | N . | Sensitivity (%) . | Specificity . | PFS hazard ratio . | Lead time . | Reference . |
|---|---|---|---|---|---|---|---|---|---|
| Chauhan | 2023 | Bespoke PCR (uCAPP-SeQ + ULP-WGS) | MIBC | 74 | 87 | NR | 3.00 | NR | Chauhan22 |
| Zhang | 2023 | Bespoke PCR (PredicineBEACON) | MIBC | 20 | 100 | 99% | NR | NR | Zhang23 |
| Christensen | 2023 | Bespoke 50-gene PCR | MIBC | 92 | 72 | 65% | NR | NR | Christensen24 |
| Author . | Year . | Assay . | Setting . | N . | Sensitivity (%) . | Specificity . | PFS hazard ratio . | Lead time . | Reference . |
|---|---|---|---|---|---|---|---|---|---|
| Chauhan | 2023 | Bespoke PCR (uCAPP-SeQ + ULP-WGS) | MIBC | 74 | 87 | NR | 3.00 | NR | Chauhan22 |
| Zhang | 2023 | Bespoke PCR (PredicineBEACON) | MIBC | 20 | 100 | 99% | NR | NR | Zhang23 |
| Christensen | 2023 | Bespoke 50-gene PCR | MIBC | 92 | 72 | 65% | NR | NR | Christensen24 |
Abbreviations: CAPP-Seq, CAncer personalized profiling by deep sequencing; MIBC, muscle-invasive bladder cancer; MRD, molecular residual disease; NAC, neoadjuvant chemotherapy; NR, not reported; WES, whole exome sequencing; WGS, whole-genome sequencing.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
